About the N-Assay patent: US Patent 9034583
From the paper: http://www.hindawi.com/journals/idog/aip/5293034/
Conflict of Interest: The authors report no financial interest in Nanologix, Inc. Dr. Jonath
Conflict of Interest: The authors report no financial interest in Nanologix, Inc. Dr. Jonathan Faro
20 is named as a co-inventor of the ELISA method utilized in this study, Patent 9034583, granted
21 May 19,2015.
http://www.freepatentsonline.com/9034583.html
Rapid enzyme-linked immunosorbent assay for detection and identification of pathogens and determination of antimicrobial susceptibility
United States Patent 9034583
Abstract:The present invention provides a rapid, highly sensitive and specific enzyme-linked immunosorbent assay (ELISA), referred to as N-Assay, a device, and a kit, for detection and identification of microorganisms in a sample, in thirty minutes or less, with little or no interference from non-target microorganisms. The present invention also provides for simultaneous determination of antimicrobial susceptibility of microorganism in the N-Assay.
............................................................................................................................................................................................................
About the Journal and title of the paper: (dates received and accepted)
Hindawi Publishing Corporation is one of the world’s largest publishers of peer-reviewed, fully Open Access journals. Hindawi’s journals maintain the highest standards of peer review, managed by independent academic Editors from prominent institutions around the world. Hindawi’s journals are indexed in the leading abstracting and indexing databases, including the Web of Science, Scopus, PubMed, INSPEC, Mathematical Reviews, and Chemical Abstracts.
Hindawi is a member of several industry organizations, including the Association of Learned and Professional Society Publishers (ALPSP), the International Association of Scientific, Technical and Medical Publishers (STM), the Open Access Scholarly Publishers Association (OASPA), the Committee on Publication Ethics (COPE), the International Digital Publishing Forum (IDPF), the National Information Standards Organization (NISO), the Publishers International Linking Association (Crossref), the Open Researcher and Contributor ID (ORCID), and Counting Online Usage of Networked Electronic Resources (COUNTER).
All of Hindawi’s content is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as with the LOCKSS initiative. In December 2006, Hindawi was certified with the ISO 9001:2000 quality management system by TÜV Rheinland, and this was updated to ISO 9001:2008 by BSI.
Contact Information
Email: hindawi@hindawi.com
Research Article
Development of a novel test for simultaneous bacterial identification and antibiotic susceptibility
Jonathan Faro, Malika Mitchell, Yuh-Jue Chen, Sarah Kamal, Gerald Riddle, and Sebastian Faro
Received 13 May 2016; Accepted 10 August 2016
..............................................................................................................................................................
From the paper: http://www.hindawi.com/journals/idog/aip/5293034/
Conflict of Interest: The authors report no financial interest in Nanologix, Inc. Dr. Jonath
Conflict of Interest: The authors report no financial interest in Nanologix, Inc. Dr. Jonathan Faro
20 is named as a co-inventor of the ELISA method utilized in this study, Patent 9034583, granted
21 May 19,2015.
http://www.freepatentsonline.com/9034583.html
Rapid enzyme-linked immunosorbent assay for detection and identification of pathogens and determination of antimicrobial susceptibility
United States Patent 9034583
Abstract:The present invention provides a rapid, highly sensitive and specific enzyme-linked immunosorbent assay (ELISA), referred to as N-Assay, a device, and a kit, for detection and identification of microorganisms in a sample, in thirty minutes or less, with little or no interference from non-target microorganisms. The present invention also provides for simultaneous determination of antimicrobial susceptibility of microorganism in the N-Assay.
............................................................................................................................................................................................................
About the Journal and title of the paper: (dates received and accepted)
Hindawi Publishing Corporation is one of the world’s largest publishers of peer-reviewed, fully Open Access journals. Hindawi’s journals maintain the highest standards of peer review, managed by independent academic Editors from prominent institutions around the world. Hindawi’s journals are indexed in the leading abstracting and indexing databases, including the Web of Science, Scopus, PubMed, INSPEC, Mathematical Reviews, and Chemical Abstracts.
Hindawi is a member of several industry organizations, including the Association of Learned and Professional Society Publishers (ALPSP), the International Association of Scientific, Technical and Medical Publishers (STM), the Open Access Scholarly Publishers Association (OASPA), the Committee on Publication Ethics (COPE), the International Digital Publishing Forum (IDPF), the National Information Standards Organization (NISO), the Publishers International Linking Association (Crossref), the Open Researcher and Contributor ID (ORCID), and Counting Online Usage of Networked Electronic Resources (COUNTER).
All of Hindawi’s content is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as with the LOCKSS initiative. In December 2006, Hindawi was certified with the ISO 9001:2000 quality management system by TÜV Rheinland, and this was updated to ISO 9001:2008 by BSI.
Contact Information
Email: hindawi@hindawi.com
Research Article
Development of a novel test for simultaneous bacterial identification and antibiotic susceptibility
Jonathan Faro, Malika Mitchell, Yuh-Jue Chen, Sarah Kamal, Gerald Riddle, and Sebastian Faro
Received 13 May 2016; Accepted 10 August 2016
..............................................................................................................................................................
7
